Sierra Summit Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History
Sierra Summit Advisors LLC
- $462 Billion
- Q1 2025
A detailed history of Sierra Summit Advisors LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 26,478 shares of CPRX stock, worth $629,646. This represents 0.14% of its overall portfolio holdings.
Number of Shares
26,478Holding current value
$629,646% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
388Shares Held
99.1MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$445 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$202 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$132 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$81.4 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$74.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.45B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...